Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Binimetinib and Encorafenib in Advanced Solid Tumors With Non-V600E BRAF Mutations
NCT03839342Phase 2Active, not recruiting
- Sponsor
- University Health Network
- Start
- Jun 2019
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of binimetinib, encorafenib in solid tumor, sponsored by University Health Network. Started Jun 2019; status: active, not recruiting.
02
Drugs
binimetinibencorafenib
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT03839342.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03839342.